nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Convulsion—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Flecainide—Tachycardia—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Flecainide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Flecainide—Convulsion—Methylprednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Flecainide—Hypertension—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Flecainide—Hypertension—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Flecainide—Myalgia—Triamcinolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Flecainide—Pneumonia—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Flecainide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Flecainide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Flecainide—Eye disorder—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Flecainide—Anxiety—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Flecainide—Flushing—Prednisone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Flecainide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Flecainide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Flecainide—Discomfort—Triamcinolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Flecainide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Flecainide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Flecainide—Renal failure—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Flecainide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Flecainide—Immune system disorder—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Flecainide—Malaise—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Flecainide—Malaise—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Flecainide—Oedema—Triamcinolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Flecainide—Vertigo—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Flecainide—Vertigo—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Flecainide—Syncope—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Flecainide—Syncope—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Flecainide—Haematuria—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Flecainide—Shock—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Flecainide—Insomnia—Prednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Flecainide—Alopecia—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Flecainide—Shock—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Flecainide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Flecainide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Flecainide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Flecainide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Flecainide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Flecainide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Flecainide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Flecainide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Flecainide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Flecainide—Convulsion—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Flecainide—Convulsion—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Flecainide—Hypertension—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Flecainide—Hypertension—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Flecainide—Myalgia—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Flecainide—Myalgia—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Flecainide—Anxiety—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Flecainide—Anxiety—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Flecainide—Discomfort—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Flecainide—Discomfort—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Flecainide—Hypotension—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Flecainide—Pain—Prednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Flecainide—Vision blurred—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Flecainide—Oedema—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Flecainide—Oedema—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Flecainide—Insomnia—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Flecainide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Flecainide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Flecainide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Flecainide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Flecainide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Flecainide—Shock—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Shock—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Flecainide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Flecainide—Tachycardia—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Flecainide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Flecainide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Flecainide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Flecainide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Flecainide—Malaise—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Flecainide—Vertigo—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Flecainide—Syncope—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Flecainide—Anorexia—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Flecainide—Anorexia—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Flecainide—Urticaria—Prednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Flecainide—Fatigue—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Flecainide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Flecainide—Pain—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Flecainide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Flecainide—Hypotension—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Flecainide—Hypotension—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Flecainide—Convulsion—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Flecainide—Hypertension—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Myalgia—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Arthralgia—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Flecainide—Anxiety—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Flecainide—Alopecia—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Flecainide—Insomnia—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Flecainide—Insomnia—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Flecainide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Flecainide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Flecainide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Flecainide—Discomfort—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Flecainide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Flecainide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Flecainide—Urticaria—Triamcinolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Flecainide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Oedema—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Flecainide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Flecainide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Flecainide—Fatigue—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Flecainide—Fatigue—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Flecainide—Shock—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Flecainide—Pain—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Flecainide—Pain—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Flecainide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Flecainide—Tachycardia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Flecainide—Skin disorder—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Flecainide—Anorexia—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Flecainide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Flecainide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Flecainide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Flecainide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Flecainide—Malaise—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Flecainide—Vertigo—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Flecainide—Urticaria—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Urticaria—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Dizziness—Prednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Asthenia—Triamcinolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Abdominal pain—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Flecainide—Asthenia—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Flecainide—Insomnia—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Flecainide—Paraesthesia—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Flecainide—Pruritus—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Flecainide—Cough—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Flecainide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Flecainide—Convulsion—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Flecainide—Dyspepsia—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Flecainide—Chest pain—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Myalgia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Decreased appetite—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Rash—Prednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Dermatitis—Prednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Flecainide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Flecainide—Fatigue—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Flecainide—Headache—Prednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Flecainide—Discomfort—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Flecainide—Constipation—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Flecainide—Confusional state—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Flecainide—Dizziness—Triamcinolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Flecainide—Dizziness—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Flecainide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Asthenia—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Asthenia—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Nausea—Prednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Flecainide—Pruritus—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Flecainide—Pruritus—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Flecainide—Vomiting—Triamcinolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Flecainide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Flecainide—Rash—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Flecainide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Flecainide—Anorexia—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Flecainide—Rash—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Urticaria—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Headache—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Headache—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Abdominal pain—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Body temperature increased—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Flecainide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Flecainide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Flecainide—Hypotension—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Flecainide—Dizziness—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Flecainide—Dizziness—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Flecainide—Insomnia—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Flecainide—Nausea—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Flecainide—Nausea—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Flecainide—Somnolence—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Flecainide—Vomiting—Betamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Flecainide—Vomiting—Dexamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Rash—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Rash—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Dermatitis—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Fatigue—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Flecainide—Headache—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Flecainide—Headache—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Flecainide—Asthenia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Flecainide—Pain—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Flecainide—Pruritus—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Flecainide—Diarrhoea—Prednisone—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Flecainide—Nausea—Betamethasone—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Flecainide—Nausea—Dexamethasone—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Flecainide—Urticaria—Methotrexate—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Flecainide—Dizziness—Prednisone—psoriatic arthritis	0.000951	0.000951	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Flecainide—Vomiting—Prednisone—psoriatic arthritis	0.000914	0.000914	CcSEcCtD
Flecainide—Rash—Prednisone—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Flecainide—Dermatitis—Prednisone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Flecainide—Headache—Prednisone—psoriatic arthritis	0.000901	0.000901	CcSEcCtD
Flecainide—Asthenia—Methotrexate—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Flecainide—Nausea—Prednisone—psoriatic arthritis	0.000854	0.000854	CcSEcCtD
Flecainide—Pruritus—Methotrexate—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000822	0.000822	CcSEcCtD
Flecainide—Dizziness—Methotrexate—psoriatic arthritis	0.000795	0.000795	CcSEcCtD
Flecainide—Vomiting—Methotrexate—psoriatic arthritis	0.000764	0.000764	CcSEcCtD
Flecainide—Rash—Methotrexate—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—psoriatic arthritis	0.000757	0.000757	CcSEcCtD
Flecainide—Headache—Methotrexate—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Flecainide—Nausea—Methotrexate—psoriatic arthritis	0.000714	0.000714	CcSEcCtD
